Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients MS Jawahar, VV Banurekha, CN Paramasivan, F Rahman, ... PLoS One 8 (7), e67030, 2013 | 122 | 2013 |
Role of LTA4H polymorphism in tuberculosis-associated immune reconstitution inflammatory syndrome occurrence and clinical severity in patients infected with HIV G Narendran, D Kavitha, R Karunaianantham, L Gil-Santana, ... PLoS One 11 (9), e0163298, 2016 | 21 | 2016 |
4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India–a randomised clinical trial B Velayutham, MS Jawahar, D Nair, P Navaneethapandian, C Ponnuraja, ... Tropical Medicine & International Health 25 (4), 483-495, 2020 | 15 | 2020 |
Effect of moxifloxacin on QTc interval in adults with pulmonary tuberculosis D Nair, B Velayutham, M Marimuthu, PGD Navaneethapandian, ... The National medical journal of India 31 (1), 58-59, 2018 | 6 | 2018 |
Assessment of panel slides prepared by phenol ammonium sulphate and NALC methods for proficiency testing R Radhakrishnan, MMP Kumar, S Prabuseenivasan, S Anbarasu, ... The International journal of tuberculosis and lung disease 16 (3), 394-397, 2012 | | 2012 |